Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental design for drug development: a Bayesian approach.

D A Berry1

  • 1School of Statistics, University of Minnesota, Minneapolis 55455.

Journal of Biopharmaceutical Statistics
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).

Breast cancer research and treatment·2016
Same author

Emerging innovations in clinical trial design.

Clinical pharmacology and therapeutics·2015
Same author

The Signature Program: Bringing the Protocol to the Patient.

Clinical pharmacology and therapeutics·2015
Same author

CYP2D6 genotype and adjuvant tamoxifen.

Clinical pharmacology and therapeutics·2014
Same author

Assessment of local vocal fold deformation characteristics in an in vitro static tensile test.

The Journal of the Acoustical Society of America·2011
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

The Bayesian approach offers a unified framework for drug development, streamlining experimental design choices. This method facilitates calculating predictive probabilities, enhancing decision-making throughout the drug lifecycle.

Area of Science:

  • Biostatistics
  • Pharmaceutical Sciences
  • Clinical Trial Design

Background:

  • Drug development involves complex decision-making across multiple phases.
  • Selecting optimal experimental designs is crucial for efficient drug development.
  • Traditional statistical methods may not fully integrate all aspects of the decision process.

Purpose of the Study:

  • To present a Bayesian approach for experimental design in drug development.
  • To demonstrate the application of this approach in clinical trial design.
  • To compare Bayesian and classical statistical perspectives on experimental design.

Main Methods:

  • Utilizing Bayesian inference for decision-making and experimental design.
  • Calculating predictive probabilities of potential study outcomes.

Related Experiment Videos

  • Illustrating the methodology with a specific clinical trial design example.

    • Main Results:

    • The Bayesian approach provides an integrated framework for drug development decisions.
    • It offers a natural and convenient method for selecting experimental designs.
    • Predictive probabilities are essential for evaluating and comparing design strategies.

    Conclusions:

    • The Bayesian approach offers a cohesive and powerful framework for experimental design in drug development.
    • It enhances the evaluation of design strategies through predictive probability calculations.
    • This approach provides a valuable alternative to classical statistical methods in pharmaceutical research.